The impact of ocular surface disease in glaucoma treatment

This article considers the impact of ocular surface disease on patients with glaucoma and the implications it can have on quality of life and adherence to treatment

To view this content, please log in

Not a member or subscriber? Join AOP today for access to a whole range of benefits, or subscribe to OT for immediate access to our premium content.


OT CPD See all